HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Nanotech Metrics, Safety Should Trump Size, Experts Say

This article was originally published in The Rose Sheet

Executive Summary

Evaluations of novel products based on nanotechnology should focus on safety and efficacy more than particle size, presenters at the FDLI annual conference say. The Project on Emerging Nanotechnologies is updating its product inventory to include more nanomaterial safety data.

You may also be interested in...



EC's Delayed Nano Inventory Reflects Notification Errors, Definitional Challenges

A European Commission official says the long-awaited cosmetic nanomaterials inventory has been delayed due to notification inaccuracies, likely reflecting challenges associated with the "nanomaterial" definition enshrined in regulations. Nevertheless, the EC says it is nearing completion, and trade group Cosmetics Europe believes the catalogue could release this summer.

Industry Faces Measurement Challenges Under EC Nanomaterial Regs

The European Commission’s recommended definition of “nanomaterial,” which could be wrapped into the recast Cosmetics Directive, appears to be relatively simple. In practice, measuring particles against the standard offers a number of technological challenges, a report from the EC’s Joint Research Centre suggests.

Consumers Burned By “Nano-Free” Sunscreens? NGO Cries “Scandal”

Friends of the Earth claims that materials supplier Antaria misleads its customers and ultimately consumers by billing its ZinClear-IM sunscreen ingredient as “nano-free” when third-party testing shows it contains “clusters” of nanoparticles. How nanotechnology should be defined, and exactly what materials warrant special attention from a regulatory standpoint, continues to be a matter of debate internationally.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel